Vanguard Group’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $106M | Sell |
|
|||||
|
2025
Q2 | $93M | Buy |
|
|||||
|
2025
Q1 | $165M | Sell |
|
|||||
|
2024
Q4 | $172M | Sell |
|
|||||
|
2024
Q3 | $141M | Sell |
|
|||||
|
2024
Q2 | $226M | Buy |
|
|||||
|
2024
Q1 | $247M | Sell |
|
|||||
|
2023
Q4 | $305M | Sell |
|
|||||
|
2023
Q3 | $273M | Buy |
|
|||||
|
2023
Q2 | $292M | Buy |
|
|||||
|
2023
Q1 | $403M | Sell |
|
|||||
|
2022
Q4 | $401M | Buy |
|
|||||
|
2022
Q3 | $294M | Buy |
|
|||||
|
2022
Q2 | $364M | Buy |
|
|||||
|
2022
Q1 | $421M | Sell |
|
|||||
|
2021
Q4 | $446M | Sell |
|
|||||
|
2021
Q3 | $457M | Buy |
|
|||||
|
2021
Q2 | $454M | Buy |
|
|||||
|
2021
Q1 | $457M | Buy |
|
|||||
|
2020
Q4 | $420M | Buy |
|
|||||
|
2020
Q3 | $301M | Sell |
|
|||||
|
2020
Q2 | $314M | Sell |
|
|||||
|
2020
Q1 | $305M | Buy |
|
|||||
|
2019
Q4 | $388M | Sell |
|
|||||
|
2019
Q3 | $408M | Buy |
|
|||||
|
2019
Q2 | $360M | Buy |
|
|||||
|
2019
Q1 | $351M | Buy |
|
|||||
|
2018
Q4 | $280M | Buy |
|
|||||
|
2018
Q3 | $403M | Sell |
|
|||||
|
2018
Q2 | $405M | Buy |
|
|||||
|
2018
Q1 | $332M | Buy |
|
|||||
|
2017
Q4 | $282M | Buy |
|
|||||
|
2017
Q3 | $287M | Buy |
|
|||||
|
2017
Q2 | $300M | Sell |
|
|||||
|
2017
Q1 | $238M | Buy |
|
|||||
|
2016
Q4 | $224M | Buy |
|
|||||
|
2016
Q3 | $208M | Buy |
|
|||||
|
2016
Q2 | $192M | Buy |
|
|||||
|
2016
Q1 | $153M | Buy |
|
|||||
|
2015
Q4 | $150M | Buy |
|
|||||
|
2015
Q3 | $128M | Sell |
|
|||||
|
2015
Q2 | $128M | Buy |
|
|||||
|
2015
Q1 | $106M | Buy |
|
|||||
|
2014
Q4 | $88M | Buy |
|
|||||
|
2014
Q3 | $78.4M | Buy |
|
|||||
|
2014
Q2 | $72.8M | Buy |
|
|||||
|
2014
Q1 | $69.4M | Buy |
|
|||||
|
2013
Q4 | $68.2M | Buy |
|
|||||
|
2013
Q3 | $49.5M | Buy |
|
|||||
|
2013
Q2 | $43.2M | Buy |
|